<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>TTK Healthcare Ltd. (TTKHLTCARE) — Tipsheet</title>
    <link>https://tipsheet.markets/company/ttkhltcare/</link>
    <atom:link href="https://tipsheet.markets/company/ttkhltcare/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering TTK Healthcare Ltd. (TTKHLTCARE), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Tue, 28 Jul 2026 14:38:36 GMT</lastBuildDate>
    <item>
      <title>TTK Healthcare profit falls 19% on exceptional charges</title>
      <link>https://tipsheet.markets/ttkhltcare-ttk-healthcare-profit-falls-19-on-exceptional-charges-104082/</link>
      <guid isPermaLink="true">https://tipsheet.markets/ttkhltcare-ttk-healthcare-profit-falls-19-on-exceptional-charges-104082/</guid>
      <pubDate>Sat, 30 May 2026 13:53:58 GMT</pubDate>
      <description>Revenue grew 7%, but the bottom line shrank. The filing is routine.</description>
      <content:encoded><![CDATA[<p><em>Revenue grew 7%, but the bottom line shrank. The filing is routine.</em></p>
<h3>What’s new</h3><ul><li>Revenue rose 7% to ₹85,728 lakhs in FY26.</li><li>Net profit dropped 19% to ₹6,568 lakhs due to exceptional items.</li><li>Board recommended a ₹10 per share dividend and reappointed the executive chairman.</li></ul>
<h3>Why it matters</h3><p>This is a routine filing for a stable, low-volatility micro-cap. The results were anticipated, and the governance moves are procedural. The filing adds no new information for investors to act on.</p>
<h3>What we’re watching</h3><ul><li>The specific nature of the exceptional items weighing on profit.</li><li>Any commentary on underlying volume or margin trends.</li><li>Management's outlook for the next fiscal year.</li></ul>
<h3>The full read</h3><p>TTK Healthcare's FY26 results are stable. Revenue climbed <strong>7%</strong> to <strong>₹85,728 lakhs</strong>. Net profit fell <strong>19%</strong> to <strong>₹6,568 lakhs</strong>, dragged by exceptional items. The board maintained the <strong>₹10</strong> per share dividend and reappointed the executive chairman. Both are procedural. No new strategy. No catalyst for a re-rating. The numbers match expectations. For a micro-cap with a steady, low-volatility business, that's the story.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=507747&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=TTKHLTCARE">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>